Proliferation kinetics and prediction of chemotherapeutic effect in adult acute leukemia according to the FAB classification.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D002455:Cell Division; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000145:classification / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D014411:Neoplastic Stem Cells; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis
D003561:Cytarabine; D011239:Prednisolone; D015122:Mercaptopurine; D003630:Daunorubicin